Supplementary Figures Supplementary Table 1: Exercise regulated genes identified by custom microarray analysis. Abbreviation Full Length Name Fold Upregulation Standard Error P value (t-test) Accession # Growth Factor Signaling VGF VGF (nonacronymic) 3.60 0.36 6.11E-07 M60525 ERK2 extracellular signal-related kinase 2 1.86 0.24 0.00874547 M64300 MAPKP3 phosphatase MKP-3 1.76 0.32 0.05164833 X94185 GRB2 growth factor receptor bound protein 2 1.75 0.30 0.02940078 NM_030846 NTRK2 neurotrophic tyrosine kinase, receptor, type 2 1.75 0.39 0.06407797 NM_006180 CSF3G colony stimulating factor 3 1.74 0.27 0.00987398 NM_017104 MEK2 mitogen-activated, kinase 2 1.74 0.25 0.01779264 L14936 NEUR Neuritin 1.61 0.26 0.04207812 NM_008738 MAGED1 melanoma antigen, family D, 1 1.54 0.21 0.03320883 NM_053409 Transcription Factors & IEG NARP neuronal activity-regulated pentraxin 3.14 0.93 0.01175453 S82649 EGR1 early growth response 1 2.48 0.65 0.01038235 NM_012551 EGR2 early growth response 2 2.32 0.72 0.03859933 AB032420 EGR4 early growth response 4 2.10 0.51 0.03819028 NM_019137.1 ELK1 Ets-domain protein ELK1 2.04 0.30 0.00856434 NM_007922 Neurotransmitter/ Synaptic Signaling GRP78 glucose-regulated protein 78 2.10 0.28 0.0050497 S63521 SYNCAM synaptic cell adhesion molecule 1 2.05 0.41 0.01141024 AF539424 IL-16 interleukin 16 1.87 0.29 0.01614977 NM_010551 Gat1 sodium and chloride-dependent GABA transporter 1 1.79 0.37 0.04690756 NM_024371 GAD67 glutamic acid decarboxylase 67 1.74 0.34 0.03087761 M76177 LPHH1 R CL1BA; Latrophilin 1 GPCR 1.73 0.23 0.01251362 NM_022962 GIT1 G protein-coupled receptor kinase- interactor 1 1.60 0.26 0.04451577 NM_031814 GPCR37 G protein-coupled receptor 37-like 1 1.58 0.26 0.05251082 NM_134438 NPY neuropeptide Y 1.56 0.23 0.03851329 NM_012614 MFGE8 milk fat globule-EGF factor 8 1.55 0.24 0.04537911 NM_012811 Gabrr1 GABA receptor rho-1 subunit 1.50 0.21 0.04161858 NM_017291 SCG-2 secretogranin II 1.48 0.21 0.05073705 NM_022669 Syn-1 synapsin 1 1.47 0.21 0.04936608 X04655 Kinases, Phosphatases, & Enzymes Pkcl atypical protein kinase C lambda/iota 2.40 0.71 0.02662912 AB020615 STEP46 striatal enriched phosphatase 46 2.37 0.43 0.00290866 XM_193035 LDHA lactate dehydrogenase-A 1.90 0.38 0.03151884 NM_017025 E214K 14-kDa ubiquitin-conjugating enzyme 1.76 0.29 0.01027437 M62388 ODC1 ornithine decarboxylase 1.72 0.34 0.04952544 NM_012615 PEPCK phosphoenolpyruvate carboxykinase (GTP) 1.62 0.27 0.04460906 AH007109 Significantly regulated genes are shown, including abbreviations, full-length names, fold regulation, standard error, p values (t-test), and accession numbers. The genes arranged by functional group. Twenty seven of the 33 genes identified have not been previously reported to be regulated by exercise in brain.
33
Embed
supplementary figures 091807 · 2010-02-12 · Gat1* 102 103 GABA transporter; Gat1 mRNA is expressed in GABAergic neurons and in non-GABAergic neurons and/or glial cells which are
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Significantly regulated genes are shown, including abbreviations, full-length names, fold regulation, standard error, p values (t-test), and accession numbers. The genes arranged by functional group. Twenty seven of the 33 genes identified have not been previously reported to be regulated by exercise in brain.
Abbreviation Function Growth Factor Signaling VGF+
Neuropeptide regulated by electroconvulsive shock 1 and neurotrophins (e.g. BDNF or NGF) 2-4 that functions in energy balance 5, learning and synaptic activity 6. Reported to be regulated by exercise in brain 7.
ERK2#
Serine/threonine kinase involved in growth factor signaling 8; Reported to be regulated by9 exercise in skeletal muscle 10 but not reported to be regulated by exercise in the hippocampus.
MAPKP3*
MAPKP3 (MKP3) is a dual specificity phosphatase (DSP) that selectively dephosphorylates phosphotyrosine and phosphothreonine residues within MAPK that are required for its activation11; MAPK family regulates gene expression, cell proliferation, differentiation, neuronal survival, and programmed cell death 12-19; MKP3 acts predominantly on ERK1 and ERK2 but not on JNK/SAPK or p38 MAP kinases 20-22; MKP3 is expressed in brain and has a cytosolic localization 23,24; it is also induced by nerve growth factor (NGF) in differentiating PC12 cells 25; cerebral hypoxia results in increased expression of MKP1 and MKP3 (MAPKP3) via a nitric oxide mechanism 26; MKP3 plays a role in regulating gluconeogenic gene expression and hepatic gluconeogenesis where altered expression of MKP3 and/or function in liver may contribute to the pathogenesis of insulin resistance and type II diabetes27. There are no reports on MAPKP3 being regulated by exercise in brain.
GRB2*
Adaptor protein involved in ERK/MAPK pathway where following tyrosine kinase receptor activation GRB2 mediates the interaction between SHC and SOS (son of sevenless, guanylnucleotide exchange factor) leading to activation of RAS 28,29. Not regulated in skeletal muscle following exercise 30. No reports on GRB2 being regulated by exercise in brain.
NTRK2+
Preferred receptor for BDNF; mediates BDNF/NT-3 survival of fibroblasts 31; mediates the effects of BDNF on hippocampal LTP 32; modulates dendritic spine development 33; TrkB and TrkC signaling required for maturation and synaptogenesis of hippocampal connections 34; BDNF stimulation of NPY requires both TrkB phospholipase C gamma and Shc binding sites 35; mediates hippocampal plasticity by recruiting PLCgamma and phosphorylating CaMKIV and CREB 36; BDNF recruits full-length TrkB receptor into cholesterol-rich lipid rafts which may provide a mechanism for synaptic modulation 37. Reported to be regulated by exercise in brain 38.
CSF3G#
Haematopoietic growth factor that works by encouraging the bone marrow to produce more white blood cells; reported to be upregulated in blood of humans after exercise 39,40. Interestingly, there is a recent review stating that CSF3G is a potential novel neuroprotective factor 41. Also CSF3G reported recently to induce neurogenesis via VEGF 42 and angiogenesis 43. CSF3G provides trophic support to cholinergic neurons 44 which may be another mechanism where by exercise achieves its beneficial effects. There is also a report specifically discussing the potential for CSF3G as a novel neurotrophic factor that may have therapeutic value in treating neurodegenerative diseases 45. Reported to be regulated in blood in humans following exercise 46. Not reported to be regulated by exercise in the brain.
MEK2#
Kinase in MAPK kinase pathway involved in cell proliferation and differentiation; involved in growth factor signaling; MEK2/ERK involved in
growth arrest while MEK1/ERK activation preferentially provides proliferative signals at the G1/S boundary 47. Following resistance exercise a MEK inhibitor (PD098059) blocked exercise induced muscle protein synthesis 48. Exercise of human skeletal muscle activates the MAPK pathway (RSK2, MEK1, Raf-1), but not MEK2 in this study 49. Another report of exercise in human skeletal muscle does report increased phosphorylation of ERK 1&2 and MEK 1&2 phosphorylation) 50. There are no studies reporting MEK2 regulation by exercise in the brain.
NEUR*
Activity-regulated gene (immediate early gene) encoding a membrane-bound ligand that regulates dendritic and axonal arbor growth and synaptic maturation that is involved in synaptic plasticity 51-54. Promotes neuritogenesis and is regulated by neurotrophins (trkB mediated), glutamate, depolarization, and seizures 1,53-55 No reports of exercise regulation in brain.
MAGED1*
Novel member of the MAGE/necdin gene family whose members were shown to promote neuronal differentiation and cell arrest 56. Interacts with neurotrophin p75 receptor and facilitates NGF-dependent apoptosis. MAGED1 is able to overcome the anti-apoptotic effect of Bcl-2 57. MAGED1 was identified as a binding partner for the p75 neurotrophin receptor, the apoptosis inhibitory protein XIAP, and Dlx/MSX homeodomain proteins, where it is reported to block cell cycle progression and enhance apoptosis 58,59. No reports on being regulated by exercise in brain.
Transcription Factors & IEG NARP+
Immediate early gene that augments synaptic plasticity possibly via excitatory synaptogenesis where it clusters AMPA receptors 60,61; induced by synaptic activity and promotes neurite outgrowth 62; acute administration of methamphetamine induces NARP mRNA in PFC and reduces it in hippocampus 63; Referenced to be regulated by exercise in hippocampus 7.
EGR1+
Immediate early gene involved in neuronal plasticity induced by growth factors and synaptic activity 64-67; induced by BDNF 68; up regulated following classical conditioning 69 and plays a role in memory formation during a hippocampal spatial learning task 70; involved in late-phase long term potentiation, required for hippocampus-dependent long-term memory formation and for reconsolidation of memories via regulation of Arc 71. EGR1 activation via cAMP regulates synapsin 1 expression 72; up regulated following environmental enrichment in hippocampus 73; reported to be regulated by exercise in hippocampus 7,74.
EGR2*
Immediate early gene 66,75; regulates myelin protein zero (Mpz) gene which is critical for myelination of the peripheral nervous system 76; inhibition of EGR2 may contribute to glucocorticoid-induced osteoporosis 77; induction of EGR2 activates downstream transcription factors including c-fos, SRF, and c-myc which are involved in cell proliferation 78; role in PTEN-induce apoptotic pathway 79; Up regulated following environmental enrichment in hippocampus 73. No reports of being regulated by exercise in brain.
EGR4*
Immediate early gene involved in cellular growth and differentiation 66,80; role in male fertility 81; in T cells EGR4 & EGR3 interact with NF-kappa B and control inflammatory cytokine gene transcription 82; induced by seizure and vibrissae stimulation 83; up regulated following environmental enrichment in hippocampus 73. No reports of being regulated by exercise in brain.
ELK1*
Transcription factor that can bind to purine-rich DNA sequences and can form a ternary complex with serum response factor (SRF) and the ETS and SRF motifs of the FOS serum response element 84,85; involved in hippocampal plasticity via
the MAPK pathway 86,87; signaling pathways of TrkB-ERK1/2-CREB/Elk-1 are highly activated in mossy fiber organization 88; thrombin activation of the Elk1 transcription factor leads to chemokine gene expression 89. No reports of being regulated by exercise in brain.
Neurotransmitter-Synaptic Signaling
GRP78#
Molecular chaperone; reduced by dietary restriction 90; promoter region of GRP78 responds to glucose deprivation 91. Reduction of glucose concentrations first leads to repression of GRP78 mRNA abundance, followed by induction of the mRNA only when glucose is nearly exhausted 92; localized in the ER and its expression is increased by environmental stressors where it has been demonstrated to play a neuroprotective function 93. In a running rat model, acute exercise activates the synthesis and accumulation of HSP72, GRP75 and GRP78 in liver cells 94. No reports on being regulated by exercise in brain.
SYNCAM*
Brain-specific, immunoglobulin domain-containing protein that binds to intracellular PDZ-domain proteins and functions as a homophilic cell adhesion molecule at the synapse; this synaptic cell adhesion molecule is critical for synapse formation and function 95,96. No reports on being regulated by exercise in brain.
IL-16*
Cytokine; natural ligand of CD4 molecules and induces chemotaxis in CD4-expressing cells such as T cells, eosinophils, dendritic cells and monocytes; generated by posttranscriptional cleavage by caspase-3 of two large precursor isoforms; smaller protein of 67 kDa (pro-IL-16) is expressed in cells of the immune system and contains three PDZ domains, where the larger 141-kDa neuronal variant (npro-IL-16) has two additional PDZ domains in its N-terminal extension that interact with neuronal ion channels; novel target of the MAPK pathway in T-lymphocytes 97; role in the disease process underlying rheumatoid arthritis and joint destruction 98 as well as in the exacerbation of chronic adult atopic dermatitis 99. No reports on being regulated by exercise in brain.
Gat1*
GABA transporter; Gat1 mRNA is expressed in GABAergic neurons and in non-GABAergic neurons and/or glial cells which are involved in GABAergic neurotransmission 100. GAT1 deficiency leads to enhanced extracellular GABA levels resulting in an over activation of GABAA receptors responsible for a postsynaptic tonic conductance. Chronically elevated GABA levels also down-regulate phasic GABA release and reduce presynaptic signaling via GABAB receptors thus causing an enhanced tonic and a diminished phasic inhibition 101. GAT1 over expression in mouse affected testis development 102. GAT1 over expressing mice also displayed cognitive deterioration in associative learning ability and new object recognition retention 103. No reports on being regulated by exercise in brain.
GAD67*
Rate-limiting enzyme in GABA synthesis; BDNF increases GABA content in striatal cultures by presumably increasing GAD67 and GAT1 mRNA 104. Interestingly, there is decreased BDNF, TrkB, and GAD67 mRNA in the PFC of schizophrenic patients 105. No reports on being regulated by exercise in brain.
LPHH1R*
Alpha-Latrotoxin (LTX) is the venom from the black widow spider and stimulates massive exocytosis of synaptic vesicles 106. LPHH1R is the G protein-coupled receptor (GPCR) for alpha-Latrotoxin and is expressed primarily in brain 107,108; No reports on being regulated by exercise in brain.
GIT1*
G protein-coupled receptor kinase-interacting protein (GIT1) is an adaptor protein that functions as a key regulator of spine morphology and synapse formation by targeting actin regulators and altering Rac (a GTPase involved in regulating actin cyctoskeleton dynamics) activity at synapses 109. GIT1 is suggested to also act as
a scaffolding protein to enhance c-Src-dependent activation of MEK1-ERK1/2 in response to GPCRs and tyrosine kinase receptors 110. No reports on being regulated by exercise in brain.
GPCR37*
G-protein coupled receptor 37 like 1 (GPCR37) also known as Endothelin B receptor-2 precursor (ETBRLP2) was cloned and shows 60% overall homology with the Endothelin type B receptor, however it is unable to bind endothelin. It is highly expressed in the human central nervous system 111. No reports on being regulated by exercise in brain.
NPY+
Up-regulated by exercise and BDNF 112 and has diverse functions in feeding, anxiety, memory processing, and seizure activity 113,114
MFGE8*
Milk fat globule-EGF factor 8 protein (MFGE8) is a secreted glycoprotein from macrophages that can bind to apoptotic cells and bring them to phagocytes for engulfment 115-117. MFGE8 also regulates the removal of apoptotic epithelial cells during mammary gland involution and absence of this glycoprotein leads to inflammation and abnormal mammary gland remodeling 118. No reports on being regulated by exercise.
Gabrr1*
GABA is the major inhibitory neurotransmitter in the nervous system, and GABAC receptor, subunit rho 1 (Gabrr1) is a subunit of the GABAC receptor, which is a ligand-gated ion channel found in the retina, thalamus, hippocampus, pituitary, and gut 119-122. GABAC receptors may function in a diverse set of processes ranging from visual processing to regulation of sleep-wake rhythms to even pain perception, memory, and learning 122. Receptor antagonist studies of GABAC receptors have indicated altered sleep-waking behavior, inhibition of ammonia-induced apoptosis in hippocampal neurons by restoring pro-apoptotic BAD levels, and regulation of hormone release in the pituitary 120,123,124. No reports on being regulated by exercise.
SCG-2*
Secretogranin II (SCG-2) is an acidic secretory protein found in large dense core vesicles in endocrine, neuroendocrine, and neural tissues that is in the chromogranin family. Its promoter contains a CRE site 125 where it may be regulated by such transcription factors as CREB. SCG-2 is regulated by neurotrophic factors including nerve growth factor (NGF) and epidermal growth factor (EGF) 126,127 as well as second messengers such as calcium, protein kinase A, and protein kinase C 128,129. SCG-2 is processed into secreoneurin in the brain 130 and secreotneurin can elicit dopamine release from striatal slices 131. Secretoneurin may also function in processes such as chemotactic migration, inflammation, and angiogenesis 132-135. No reports on being regulated by exercise.
Syn-1+
Synapsin 1 (syn-1) is a synaptic-vesicle associated protein involved in vesicle pool formation and neurotransmitter release 136. Referenced to be regulated by exercise in brain 137.
Kinases, Phosphatases, & Enzymes Pkcl#
Atypical protein kinase C lamda/iota (Pkcl) is a kinase that resides in the cell nucleus found abundantly in lung, less abundantly in heart and skin, and very low expression in brain. It lacks a calcium regulatory domain and can be activated by phorbol esters 138,139. PKC activity has been implicated in insulin resistance and glucose transport 140,141. Following exercise in human skeletal muscle, atpical PKC (aPKC) activity was increased 142. No reports on being regulated by exercise in brain.
STEP46*
Striatal enriched phosphatase 46 (STEP46) is a cytoplasmic protein tyrosine phosphatase (PTPase) with a molecular weight of 46 kDa and is highly expressed in striatal neurons with dopamine D1-receptors. STEP can also dephosphorylate MEK and ERK. Over-expression of STEP46 induces neurite outgrowth via cAMP signaling 143-145.
LDHA#
Key enzyme in metabolism of lactate; regulatory elements in promoter region include an AP-1 binding site, 2 consensus Sp1 binding sites, and a CRE site 146; over expression perturbs glucose metabolism and insulin secretion in islet beta-cell types 147; PKC stabilizes LDHA mRNA and increases half life 148; up regulated by hypoxia via HIF-1 and CRE sites 149,150; induced by estrogen 151; regulated in the periphery by exercise 152,153. No reports to be regulated by exercise in brain.
E214K*
Up regulated following fasting in muscle, heart, liver, and kidney implicating a role of ubiquitin system in metabolic response to fasting 154; insulin and IGF1 reduce expression of E214K mRNA 155; reactive oxygen species (ROS) and mild oxidative stress increases protein degradation in skeletal muscle by up regulating E214K and other components in the ubiquitin-proteasome pathway9,156. No reports to be regulated by exercise.
ODC1#
Homodimer of 461 amino acids (in humans) that catalyzes the decarboxylation of ornithine producing, diamine putrescine which is the first and the rate limiting step in humans for the production of polyamines, compounds required for cell division. Polyamines accumulate following exercise in skeletal muscle and heart and lead to muscle adaptation to exercise 157-159. Polyamines also protect against oxidative stress 160; A beta-peptides induce ODC and subsequently polyamines which suggests a mechanism for repair from free radical damage 161. No reports of regulation by exercise in brain.
PEPCK#
Rate-limiting enzyme in gluconeogenesis in hepatic and renal cells 162; contains a CRE element in its promoter 163 which could mediate the induction of this gene by exercise in order to meet increased metabolic demands; role in maintaining blood glucose level where over expression results in symptoms of type II diabetes mellitus 164. No reference of regulation by exercise in brain.
(* ) novel exercise regulated genes, genes previous reported regulated by exercise in brain (+; 5 total) and peripheral tissues (#, 8 total). Functional information for each of the 33 exercise-regulated genes is shown above.
Supplementary Figure 1:
Immobilization stress decreases hippocampal BDNF and VGF. Sprague Dawley rats (300-350g) were subjected to 45 minutes of immobilization stress as described previously (Koo et al., 2003; Vollmayr et al., 2003) where (a) BDNF mRNA was decreased (38% DG and 20% CA3) and (b) VGF displayed a paralleled decrease (18% DG).
Supplementary Table 3: Elevated Plus Maze Infusion Data
% Open entries total # of entries time in center aCSF (n=7) 9.9±4.4 p=0.5 11.7±2.2 p=0.5 66.9±9.0 p=0.2 VGF (n=8) 9.5±3.4 p=0.5 11.6±1.5 p=0.5 73.3±3.8 p=0.2
Elevated plus maze was performed following either infusion of vehicle or VGF peptide AQEE (1ug) where there was no significant difference in the behaviors measured.
Supplementary Table 4: Genotype Data –Elevated Plus Maze
Time in Open Arms (s)
Entries into Closed Arms
Entries into Open Arms
WT Sed (n=8) 6.1±4.5 18.1±2.1 2±1.2 VGF Sed (n=8) 8.6±4.2 15.1±2.5 2±0.8
% Open entries total # of entries time in center WT Sed (n=8) 8.1±4.1 20.1±2.6 100.1±10.4 VGF Sed (n=8) 10.7±4.7 17.1±2.9 97.9±13.9
head dips stretch attend postures rears freezing
WT Sed (n=8) 6.5±1.4 14.0±1.6 3.1±0.6 0.0VGF Sed (n=8) 5.5±1.4 11.3±1.4 2.9±0.9 0.0
EPM data is shown above for wild type and VGF+/- sedentary groups.
Supplementary Table 5: Genotype Data -Open Field Test
Center Center Entire Arena Rearing
Total duration (s) Total duration
(%) Distance moved
(cm) Frequency WT Sed
(n=8) 42.5±6.1 14.2±2.0 2865.3±270.9 24.5±6.8 VGF Sed
(n=8) 44.4±6.9 14.8±2.3 4135.3±895.7 21.8±3.6 Open field test data is shown above for wild type and VGF+/- sedentary groups.
Supplementary Figure 2: In Vivo Confirmation of VGF Induced Genes Following i.c.v. Infusion Using Real time PCR
Indicates in vivo confirmation of VGF induced genes. Isolated hippocampal RNA from mice is used to make cDNA for real time PCR confirmations.
Supplementary Table 6: Gene promoter analysis
Gene Regulation CRE Site TGACGTCA EGR 1 site GC[G/T]GGGCG VGF Ex only 8 of 8; TGACGTCA 7 of 8; GCGGG_CGggc EGR2 Ex+VGF 5 of 8; TGAtGctA 6 of 8; GtTGGGgCtgg GRB2 Ex+VGF 5 of 8; TGAtGTag 6 of 8; GCaGaGGCac Neuritin Ex+VGF 5 of 8; TGAtGTtg 6 of 8; CTGGGGGCtgg ODC1 Ex+VGF 6 of 8; TGACGaCg 5 of 8; GTGGGGGGCtgg Synapsin 1 Ex+VGF 6 of 8; TGACGaCg 6 of 8; GTGGGGGGCtgg Syncam 1 Ex+VGF 6 of 8; TGAacTCA 7 of 8; CTGGGGGCGtg Growth Factor Signaling ERK2 Ex only 7 of 8; TGACGTtA 6 of 8; GCaGGGGCagg MAPKP3 Ex only 6 of 8; TGggGTCA 6 of 8; GTGGGGaCGgg NTRK2 Ex only 6 of 8; cggTGtCGTCt 6 of 8; CTGGGCagc CSF3G Ex only 7 of 8; TGACGTCt 7 of 8; GCTGGGGCaac MEK2 Ex only 7 of 8; ttgTGACccTCA 7 of 8; GGGGaGGCGac MAGED1 Ex only 5 of 8; cccTGAgGcCc 7 of 8; CTGGGGCGac Transcription Factors & IEG NARP Ex only 5 of 8; TtAgcTCA 6 of 8; GTGGGGGGGGCG EGR1 Ex only 7 of 8; TGACGTgA 7 of 8; GCGGaGGCGgg EGR4 Ex only 6 of 8; gcgTGAtGTCc 5 of 8; GTGCaGGCagg ELK1 Ex only 6 of 8; accTGAgGTCt 6 of 8; GaGGGGGCaag Neurotransmitter - Synaptic Signaling GRP78 Ex only 6 of 8; gGAgGTCA little homology IL-16 Ex only 7 of 8; cgaTGAaGTCA 6 of 8; GTGGGGGGGGt Gat1 Ex only 6 of 8; TcACGgCA 6 of 8; GCaGGGGGaag GAD67 Ex only 6 of 8; ccaTGACacCA 7 of 8; GCGGGGGCagc LPHH1R Ex only 7 of 8; tgcTGACtTCA 6 of 8; CTGGGGGgagg GIT1 Ex only 6 of 8; ttcTGAtGTCt 6 of 8; GTGGGtGCtgg GPCR37 Ex only 4 of 8; TGAgGa 5 of 8; GTGGGCacagg NPY Ex only 5 of 8; gcTGAgGcCg 6 of 8; GTGGcGGCGtc MFGE8 Ex only 5 of 8; AgGTCA 6 of 8; CTGGGGGCcag Gabrr1 Ex only 6 of 8; atgTGACcTCt 5 of 8; GTGGGGgagac SCG-2 Ex only 8 of 8; gcaTGACGTCA 4 of 8; gaaGGGGGaag Kinases, Phosphatases, & Enzymes Pkcl Ex only 6 of 8; TGAaGaCA 5 of 8; GaaGaGGCaag STEP46 Ex only 6 of 8; cggTGAaGTCc 5 of 8; GTGGGGtCagg LDHA Ex only 6 of 8; ttgTGAtGTC 7 of 8; GCGGGCGgggc E214K Ex only 4 of 8; tgGTCA little homology PEPCK Ex only 7 of 8; TGACGTaA 5 of 8; GTGGGGGtcaa
Table illustrating CREB and EGR1 conserved promoter elements in VGF and exercise regulated genes.
References:
1. Newton, S. S. et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors.
J Neurosci 23, 10841-51 (2003).
2. Levi, A., Eldridge, J. D. & Paterson, B. M. Molecular cloning of a gene sequence regulated by nerve growth
factor. Science 229, 393-5 (1985).
3. Eagleson, K. L., Fairfull, L. D., Salton, S. R. & Levitt, P. Regional differences in neurotrophin availability regulate
selective expression of VGF in the developing limbic cortex. J Neurosci 21, 9315-24 (2001).
4. Bonni, A., Ginty, D. D., Dudek, H. & Greenberg, M. E. Serine 133-phosphorylated CREB induces transcription
via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci 6, 168-83
(1995).
5. Salton, S. R. et al. VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of
energy balance. Front Neuroendocrinol 21, 199-219 (2000).
6. Alder, J. et al. Brain-Derived Neurotrophic Factor-Induced Gene Expression Reveals Novel Actions of VGF in